The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
MONTREAL's Algene Biotechnologies Corporation has announced a research agreement with the CH Cote-des-Neiges, a geriatric centre affiliated to the University of Montreal, for the identification of genes and genetic mutations that cause Alzheimer disease. The contract is for a total amount of $5.3 million and will last until December 31, 1997.
INDUSTRY CANADA has announced a $5.5 million grant is to be given to the Canadian Artificial Heart Program at the Ottawa Heart Institute. The contribution, which was approved after a scientific review by the Medical Research Council of Canada and the Natural Sciences and Engineering Research Council of Canada, will be repayable once the technology is commercialized.
The ALBERTA MEDICAL ASSOCIATION has reported that an increasing number of laboratory physicians are planning to leave Alberta after the province wide restructuring of laboratory and diagnostic services.
Boehringer Ingelheim (Canada) Ltd. announced its plan to invest approximately $10 million over a period of five years to establish a North American Information Technology "Centre of Excellence" at its Canadian headquarters in Burlington.
TORONTO's Mount Sinai Hospital announced that Scotiabank has donated $500,000 to the hospital's Samuel Lunenfeld Research Institute, to support the research of Dr. Irene Andrulis, who is investigating the genetics of breast cancer.
ONTARIO plans to invest $5.8 million over the next three years to expand diabetes education programs and services and create four new regional diabetes networks. "This will provide important front-line services to help keep people with diabetes out of hospital and improve their quality of life," said Wilson.
Med-Chem Health Care Limited, TORONTO has filed a preliminary prospectus with the Ontario Securities Commission and other provincial regulatory authorities across Canada for an initial public offering of common shares.
The government of ONTARIO has dedicated $2 million for an HIV viral load testing program. The new program will be managed by the Central Public Health Laboratory under guidelines developed by the Ontario Advisory Committee on HIV/AIDS. The guidelines call for testing based on stage of disease and whether or not someone is on antiretroviral drugs. The program will be fully operational by the end of the year; until then viral load testing will be available on a limited basis.
MONTREAL Cable system operator Cogeco Cable Inc. and GlobalMedic Inc., the Healthware company on the Internet, announced their partnership today for the development of the Cogeco Cable Health site on the Web. Cogeco Cable offers Internet surfers access to the new GlobalMedic Health site, and the subscribers to the cable modem service offered by Cogeco Cable can immediately access this new Health site at high speed. GlobalMedic developed the first healthcare site to offer an online interactive and personalized medical information service on the Internet. GlobalMedic Health site is based on an expert system that allows users to describe their symptoms. The system then suggests a diagnosis and steps for follow-up. To visit the Cogeco Cable/GlobalMedic Health site, type http://www.cgocable.ca.
Healthcare in Canada - September 1996
Healthcare in Canada - August 1996
Healthcare in Canada - July 1996
Healthcare in Canada - June 1996
Concept and Design Blue Page Productions
Copyright © 1996 STRATCOM
Last modified: November 03, 1996